Inventor
Luoheng QIN
Inventor
CN
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds32%
Y02ATechnologies for adaptation to climate change4%
PatentTitleYear
12,570,634Small molecule inhibitors of ubiquitin specific protease 1 (USP1) and uses thereof202612,398,155Thienopyridinone compounds202512,162,862Beta-lactam derivatives for the treatment of diseases202412,091,406Lysine acetyltransferase 6A (KAT6A) inhibitors and uses thereof202411,834,440Beta-lactam derivatives for the treatment of diseases202311,739,077Small molecule inhibitors of ubiquitin specific protease 1 (USP1) and uses thereof202311,691,970Pyrazolopyridinone compounds202311,384,075Quinolinone compounds202211,384,099Pyrazolopyridinone compounds2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to JANSSEN PHARMACEUTICA NV (4)· patent assignee history
2022–2026Based in CN· patent location history
2023–2026Patents assigned to INSILICO MEDICINE IP LTD (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INSILICO MEDICINE IP LTD | 5 | 2023–2026 |
| JANSSEN PHARMACEUTICA NV | 4 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 9 | 2022–2026 |